|

Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

RECRUITINGSponsored by Yale University
Actively Recruiting
SponsorYale University
Started2021-06-28
Est. completion2026-01-30
Eligibility
Age12 Years – 18 Years
Locations1 site

Summary

The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.

Eligibility

Age: 12 Years – 18 Years
Inclusion Criteria:

* Good general health, taking no medication on a chronic basis;
* age 12 to 18 years, in puberty (girls and boys: Tanner stage II-V);
* BMI \>85th for obese cohort;

Exclusion Criteria:

* Baseline creatinine \>1.0 mg; pregnancy;
* the presence of endocrinopathies (e.g. Cushing syndrome);
* cardiac or pulmonary or other significant chronic illness;
* adolescents with a psychiatric disorder or with substance abuse;
* monogenic obesity syndromes;
* use of drugs affecting intrahepatic fat content (e.g.; liraglutide, fish oil, etc.).

Conditions2

Liver DiseaseNAFLD

Locations1 site

Yale New Haven Hospital
New Haven, Connecticut, 06510
Ermena Refugjati203-215-7119ermena.refugjati@yale.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.